HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 1,945-1,956 of 7,264
Drug study icon
CompletedNCT05657691

Xanamem in depression with cognitive difficulties

What is this study about?

Researchers studied Xanamem’s effects on depressive and cognitive symptoms, alongside its safety and tolerability.

This study has finished and is no longer accepting participants.

Multiple locations, including Blacktown
DepressionMedicationAges 18–75
Countries
Australia, United Kingdom
Sponsor
Actinogen Medical
Drug study icon
CompletedEUCTR 2013-004005-11

A Double-Blind, Doubly-Randomized, Placebo-Controlled Study of Intranasal Esketamine in an Adaptive Treatment Protocol to Assess Safety and Efficacy in Treatment-Resistant Depression (SYNAPSE)

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
DepressionHistorical research record
Countries
Belgium
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedEUCTR 2014-004586-24

A Randomized, Double-blind, Multicenter, Active-Controlled Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Treatment-resistant Depression

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
DepressionHistorical research record
Countries
Belgium, Czechia, Germany, + 5 others
Sponsor
Janssen-Cilag International NV

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.